Arja Harila

Professor Arja Harila is a distinguished researcher at Uppsala University's Department of Women's and Children's Health within the Faculty of Medicine, specializing in pediatric oncological and neurological research. Her work focuses on improving outcomes for children with cancer through comprehensive clinical studies.

Her research interests span pediatric oncology, hematological malignancies, and childhood cancer survivorship, with particular emphasis on quality of life, educational outcomes, and treatment-related complications. Her investigations into acute lymphoblastic leukemia (ALL) and Hodgkin lymphoma have produced significant insights into drug responses, osteonecrosis, neuropsychiatric symptoms, and long-term survivorship issues.

Analysis of her recent publications reveals a strong focus on multinational collaborative research (particularly through Nordic consortia), registry-based epidemiological studies, and translational investigations bridging laboratory findings with clinical practice. Her work frequently addresses critical gaps in understanding treatment toxicities, survivorship challenges, and healthcare system factors affecting pediatric cancer patients.

Professor Harila actively contributes to important ethical discussions in pediatric oncology, particularly regarding confidentiality in electronic health records and regulatory frameworks for adolescent patients. Her research demonstrates consistent engagement with both clinical management challenges and broader psychosocial aspects of pediatric cancer care.